WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Adamis Pharmaceuticals Corporation - Product Pipeline Review - H2 2011

Global Markets Direct, December 2011, Pages: 47

Adamis Pharmaceuticals Corporation – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Adamis Pharmaceuticals Corporation - Product Pipeline Review - H2 2011” provides data on the Adamis Pharmaceuticals Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Adamis Pharmaceuticals Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from Adamis Pharmaceuticals Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Adamis Pharmaceuticals Corporation - Brief Adamis Pharmaceuticals Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipelin



List of Tables
List of Figures
Adamis Pharmaceuticals Corporation Snapshot
Adamis Pharmaceuticals Corporation Overview
Key Information
Key Facts
Adamis Pharmaceuticals Corporation – Research and Development Overview
Key Therapeutic Areas
Adamis Pharmaceuticals Corporation – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Adamis Pharmaceuticals Corporation – Pipeline Products Glance
Adamis Pharmaceuticals Corporation – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Adamis Pharmaceuticals Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Adamis Pharmaceuticals Corporation – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Adamis Pharmaceuticals Corporation – Drug Profiles
APC-100
Product Description
Mechanism of Action
R&D Progress
APC-200
Product Description
Mech

Customers who bought this item also bought